alexa
Reach Us +44-7482876202
Editor - Lidia Larizza | Medical Cytogenetics & Molecular Geneti | 19132
ISSN 2472-016X

Journal of Orthopedic Oncology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Lidia Larizza

Lidia Larizza
Lidia Larizza
Director
Medical Cytogenetics & Molecular Genetics Lab
Centro di Ricerche e Tecnologie Biomediche IRCCS-Istituto Auxologico Italiano
Italy
Tel: +39 02 619113041
Fax + 39 02619112464

Biography

Research Director of Laboratory of Medical Cytogenetics and Human Molecular Genetics, Istituto Auxologico Italiano, Milan (since 1993), honorary member of ECA (European Cytogeneticists Association) and honorary member of SIGU (Società Italiana Genetica Umana); Management Committee Member of BMBS COST Action BM1208 “European Network for Human Congenital Imprinting Disorders”, Member of the editorial board of “Cancer Letters" and other journals in the field of Human Genetics and Genomics

Research Interest

Pathomechanisms of Rare Diseases: Chromosomal instability syndromes with Cancer Predisposition: Rothmund-Thomson and osteosarcoma; Poikiloderma with Neutropenia and myeloid neoplasms; chromatin disorders (Cohesinopathies and Rubinstein-Taybi and related disorders) Imprinting Disorders, Genomic disorders, oncogenomics.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top